Rigenerand Srl

About:

RigeneranD is committed to develop biomedical devices supporting the culture of stem cells for pre-clinical and clinical applications.

Website: https://rigenerand-biotech.com

Twitter/X: rigenerand

Top Investors: Principia SGR

Description:

RigeneranD is committed to develop biomedical devices supporting the culture of stem cells for pre-clinical and clinical applications.Founded in 2009 by Prof. Massimo Dominici and Prof. Pierfranco Conte, as a spin-off resulting from a joint venture between biomedical company RanD and researchers from the University of Modena and Reggio Emilia, Rigenerand owns proprietary technology to develop and produce biomedical tools to empower the ex-vivo phase of stem cells expansion combining the need of high cell yield with innovative biocompatible materials.